Journal
CIRCULATION
Volume 108, Issue 4, Pages 457-463Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.CIR.0000082924.75945.48
Keywords
aging; atherosclerosis; stem cells
Funding
- NHLBI NIH HHS [HL63703, HL71536] Funding Source: Medline
Ask authors/readers for more resources
Background-Atherosclerosis is largely attributed to chronic vascular injury, as occurs with excess cholesterol; however, the effect of concomitant vascular aging remains unexplained. We hypothesize that the effect of time in atherosclerosis progression is related to obsolescence of endogenous progenitor cells that normally repair and rejuvenate the arteries. Methods and Results-Here we show that chronic treatment with bone marrow-derived progenitor cells from young nonatherosclerotic ApoE(-/-) mice prevents atherosclerosis progression in ApoE(-/-) recipients despite persistent hypercholesterolemia. In contrast, treatment with bone marrow cells from older ApoE(-/-) mice with atherosclerosis is much less effective. Cells with vascular progenitor potential are decreased in the bone marrow of aging ApoE(-/-) mice, but cells injected from donor mice engraft on recipient arteries in areas at risk for atherosclerotic injury. Conclusions-Our data indicate that progressive progenitor cell deficits may contribute to the development of atherosclerosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available